*Notice the lifting of the eyelid.
VERISOL® contains optimized collagen peptides – important components for supporting healthy skin. Administered orally at 2,500 mg daily, VERISOL® inﬂuences the skin’s collagen metabolism directly from the inside. These bioactive collagen peptides increase the skin’s moisture and slow the formation of wrinkles.
Study I, comprised of 69 women aged 35 to 55 years, revealed that VERISOL® leads to significantly higher skin elasticity within just four weeks – up to 15% more – compared to placebo treatment. Further, this effect was maintained following eight weeks of oral VERISOL® administration. Another four weeks after the last intake of the product, the VERISOL® group continued to exhibit higher skin elasticity levels than the placebo treated group.
Study II, with more than 100 women aged approximately 55 years, demonstrated that the oral administration of VERISOL® (2.5 g/day) significantly reduces wrinkles after only four weeks and resulted in substantially higher skin procollagen concentration- 65% in 60 days. (Procollagen is a precursor to actual collagen formation)
A 4 week clinical study showed a significant increase in skin elasticity. >81% of participants reported:
•Noticeably firmer skin
•Significant reduction in eye wrinkles
•Smoother skin, improved texture
*Notice reduction in deep wrinkles and lifting of the eyelid after 28 days.
*Notice reduction in brow wrinkles and lifting of eyelid after 28 days.
*Notice lifting of eyelid and reduction in "crow's feet".
Proksch E, Schunck M, Zague V, Segger D, Degwert J, Cesser S. Oral Intake of Specific Bioactive Collagen Peptides Reduces Skin Wrinkles and Increases Dermal Matrix Synthesis. Skin Pharmacol Physiol 2014; 27: 113-119
Photo courtesy Gelita AG. Based on Proksch E. Schunck M. Zague V. Segger D. Degwert J. Oesser S. Oral Intake of Specific Bioactive Collagen Peptides Reduces Skin Wrinkles and Increases Dermal Matrix Synthesis. Skin Pharmacol Physiol 2014; 27: 113-119
Bioscreen® Clinical Testing. Study #BCS 15-056